Latest News for: vach

Edit

Biomednewsbreaks - VERAXA Biotech AG And Voyager Acquisition Corp. (NASDAQ: VACH,“Voyager”) Announce $1.64 Billion Business ...

MENA FN 11 Jun 2025
(MENAFN - Investor Brand Network) VERAXA Biotech AG , a cancer therapy innovator, and proposed de-SPAC target of Voyager Acquisition Corp. (NASDAQ. VACH) announced a definitive agreement to merge in ... .
  • 1
×